SPOTLIGHT THERAPEUTICS
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.
SPOTLIGHT THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2017-01-01
Address:
Hayward, California, United States
Country:
United States
Website Url:
http://www.spotlighttx.com
Total Employee:
11+
Status:
Active
Total Funding:
80.67 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API Content Delivery Network Pound Sterling Typekit Squarespace Squarespace Add To Cart
Similar Organizations
Expressable
Expressable is an online speech therapy practice for those with a communication disorder.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Headway
Headway is a mental healthcare system provider that helps patients connect with therapists and submit insurance claims online.
Cellular Longevity, Inc., dba Loyal
Loyal is a biotechnology company developing medicines to extend dog lifespan.
Nuvalent
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Solar Foods
Solar Foods produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources.
Thermo Fisher Scientific
Thermo Fisher Scientific is a science and pharma service provider of laboratory information management & scientific data systems.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Team Builder Ventures
Team Builder Ventures investment in Series B - Spotlight Therapeutics
Emerson Collective
Emerson Collective investment in Series B - Spotlight Therapeutics
Google Ventures
Google Ventures investment in Series B - Spotlight Therapeutics
GordonMD Global Investments
GordonMD Global Investments investment in Series B - Spotlight Therapeutics
EPIQ Capital Group
EPIQ Capital Group investment in Series B - Spotlight Therapeutics
Magnetic Ventures
Magnetic Ventures investment in Series B - Spotlight Therapeutics
DNA Capital
DNA Capital investment in Series A - Spotlight Therapeutics
Google Ventures
Google Ventures investment in Series A - Spotlight Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-09-12 | Spotlight Therapeutics Appoints Nallakkan Arvindan, Ph.D., MBA, as EVP and Chief Technology Officer |
Official Site Inspections
http://www.spotlighttx.com Semrush global rank: 6.24 M Semrush visits lastest month: 1.07 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Spotlight Therapeutics"
Spotlight Therapeutics - Crunchbase Company Profile …
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively …See details»
PR - Series B — Spotlight Therapeutics
Mar 22, 2022 “Their combined breadth and depth of experience in building first-in-class pipelines, developing novel CRISPR technologies, and establishing strategic partnerships will …See details»
Spotlight Therapeutics - Overview, News & Similar companies
Mar 21, 2022 Spotlight Therapeutics contact info: Phone number: (510) 284-4799 Website: www.spotlighttx.com What does Spotlight Therapeutics do? Established in mid-2018, Spotlight …See details»
Spotlight Therapeutics Company Overview, Contact Details
Mar 22, 2022 [email protected]: 4%. [email protected]: [email protected]: 1%. [email protected]: [email protected]: 2%. See more …See details»
Spotlight Therapeutics Raises $36.5 Million Series B to …
Mar 22, 2022 Corporate Contact: Cynthia Li, PhD Spotlight Therapeutics [email protected] GordonMD Global Investments Media Contact: Mitch Ackles 646-657-9230 [email protected] Social Media ProfilesSee details»
Spotlight Therapeutics Appoints Nallakkan Arvindan, …
Sep 12, 2022 Spotlight Therapeutics, Inc. (“Spotlight”), a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologiSee details»
Spotlight Therapeutics Appoints Visionary Global Pharma Drug …
Jul 12, 2022 SAN FRANCISCO--(BUSINESS WIRE)--Spotlight Therapeutics, Inc. (“Spotlight”), a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene …See details»
Spotlight Leadership Team — Spotlight Therapeutics
Contact us. Spotlight Therapeutics 3980 Trust Way Hayward, CA 94545 . Email: [email protected]See details»
Board of Directors — Spotlight Therapeutics
Antoine Yver, MD, MSc. Independent Board Member ©Jennifer Altman/Capa PicturesSee details»
Spotlight Therapeutics Raises $36.5 Million Series B to ... - BioSpace
Mar 22, 2022 SAN FRANCISCO--(BUSINESS WIRE)-- Spotlight Therapeutics, Inc. (“Spotlight”), a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene …See details»
Spotlight Therapeutics Raises $36.5 Million Series B to Advance a ...
Mar 22, 2022 “Their combined breadth and depth of experience in building first-in-class pipelines, developing novel CRISPR technologies, and establishing strategic partnerships will …See details»
Spotlight Therapeutics’ cell-specific in vivo gene ... - Nature
Www.spotlighttx.com Spotlight Therapeutics’ cell-specific in vivo gene editingplatform,TAGE,takescenterstageSee details»
Spotlight Therapeutics Closes $30M Series A Led by GV to …
Nov 30, 2020 SAN FRANCISCO--(BUSINESS WIRE)--Spotlight Therapeutics, Inc., a biotechnology company developing non-viral gene editing therapeutics for direct in vivo editing …See details»
Spotlight Therapeutics, Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Working at Spotlight Therapeutics - Zippia
Www.spotlighttx.com. Organization Type. Private. Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The …See details»
Introduction — Spotlight Therapeutics
Current approaches for in vivo delivery of gene editors require packaging the guide RNA and Cas9 nuclease sequences as DNA within an AAV genome or as mRNA within a lipid …See details»
Attorney General Ken Paxton Sues Austin Taxpayer-Funded …
4 days ago “Drug activity and criminal behavior facilitated by this organization have hijacked an entire neighborhood,” said Attorney General Paxton. “By operating a taxpayer-funded drug …See details»
Careers - Spotlight Therapeutics
Careers at Spotlight. At Spotlight Therapeutics we are committed to a supportive and collaborative workplace that recognizes and celebrates the contributions of everyone.See details»
Checkpoint Blockade + Chemotherapy: the Right Combination for …
An emerging strategy to enhance the efficacy of immune checkpoint blockade in relapsed/refractory cancers is increasing immunogenic cell death via combination with …See details»
Science — Spotlight Therapeutics
ERNP platform designed to be safer and broaden applications. Spotlight’s e ngineered R ibo N ucleo P rotein (eRNP) platform is designed to unlock the full potential of in vivo gene editing …See details»